{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T16:54:44Z","timestamp":1757609684178,"version":"3.44.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002345","name":"Eberhard Karls Universit\u00e4t T\u00fcbingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002345","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Medulloblastoma constitutes a molecularly diverse group of malignant embryonal brain tumors. Sonic hedgehog molecular group of medulloblastoma (SHH-MB) is a highly heterogeneous tumor entity, characterized by constitutive activation of the SHH signaling pathway. Due to lack of suitable cell line models, little is known about genetic dependencies in SHH-MB outside of the SHH pathway. By performing a CRISPR-Cas9 dropout screen in SMB21 cells derived from SHH-MB in <jats:italic>Ptch<\/jats:italic>\n            <jats:sup>\n              <jats:italic>+\/\u2212<\/jats:italic>\n            <\/jats:sup> mice, we aimed to identify genetic vulnerabilities in SHH-MB. Among the top scored gene hits, members of the SNF2-family of ATP-dependent chromatin remodelers including <jats:italic>Smarca5<\/jats:italic> emerged as genetic dependencies in SHH-MB, and we validate that <jats:italic>Smarca5<\/jats:italic> knockout inhibits SHH pathway activation and SHH-MB cell proliferation. Additional genetic ablation experiments <jats:italic>in vivo<\/jats:italic> revealed that conditional deletion of <jats:italic>Smarca5<\/jats:italic> in cerebellar granule cell neuron precursors (GCNPs), the cell origin of SHH-MB, significantly reduces the proliferative capacity of GCNPs and leads to cerebellar hypoplasia in mice. Furthermore, loss of <jats:italic>Smarca5<\/jats:italic> in GCNPs in an established mouse model of SHH-MB results in prolonged survival of tumor bearing mice. Our data underline the critical role of SMARCA5 during the development of the cerebellum and the pathogenesis of SHH-MB.<\/jats:p>","DOI":"10.1038\/s41598-025-11857-3","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T11:35:15Z","timestamp":1752838515000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SMARCA5 is required for the development of granule cell neuron precursors and Sonic Hedgehog Medulloblastoma growth"],"prefix":"10.1038","volume":"15","author":[{"given":"Foteini","family":"Tsiami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Layla","family":"Drwesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surender","family":"Surender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Schittenhelm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Picketts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalind A.","family":"Segal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghazaleh","family":"Tabatabai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Merk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"11857_CR1","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.1200\/jco.2010.30.2299","volume":"28","author":"S Rutkowski","year":"2010","unstructured":"Rutkowski, S. et al. Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis. J. Clin. Oncol. 28, 4961\u20134968. https:\/\/doi.org\/10.1200\/jco.2010.30.2299 (2010).","journal-title":"J. Clin. Oncol."},{"key":"11857_CR2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00401-011-0922-z","volume":"123","author":"MD Taylor","year":"2012","unstructured":"Taylor, M. D. et al. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol. 123, 465\u2013472. https:\/\/doi.org\/10.1007\/s00401-011-0922-z (2012).","journal-title":"Acta Neuropathol."},{"key":"11857_CR3","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ccell.2018.08.004","volume":"34","author":"TC Archer","year":"2018","unstructured":"Archer, T. C. et al. Post-translational modifications, and integrative analyses reveal molecular heterogeneity within Medulloblastoma subgroups. Cancer Cell. 34, 396\u2013410e398. https:\/\/doi.org\/10.1016\/j.ccell.2018.08.004 (2018). Proteomics.","journal-title":"Cancer Cell."},{"key":"11857_CR4","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis, D. N. et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 23, 1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106 (2021).","journal-title":"Neuro Oncol."},{"key":"11857_CR5","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/s1470-2045(17)30243-7","volume":"18","author":"EC Schwalbe","year":"2017","unstructured":"Schwalbe, E. C. et al. Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study. Lancet Oncol. 18, 958\u2013971. https:\/\/doi.org\/10.1016\/s1470-2045(17)30243-7 (2017).","journal-title":"Lancet Oncol."},{"key":"11857_CR6","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ccell.2017.05.005","volume":"31","author":"FMG Cavalli","year":"2017","unstructured":"Cavalli, F. M. G. et al. Intertumoral heterogeneity within Medulloblastoma subgroups. Cancer Cell. 31, 737\u2013754e736. https:\/\/doi.org\/10.1016\/j.ccell.2017.05.005 (2017).","journal-title":"Cancer Cell."},{"key":"11857_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ccr.2008.07.005","volume":"14","author":"U Sch\u00fcller","year":"2008","unstructured":"Sch\u00fcller, U. et al. Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced Medulloblastoma. Cancer Cell. 14, 123\u2013134. https:\/\/doi.org\/10.1016\/j.ccr.2008.07.005 (2008).","journal-title":"Cancer Cell."},{"key":"11857_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/s0896-6273(00)80682-0","volume":"22","author":"RJ Wechsler-Reya","year":"1999","unstructured":"Wechsler-Reya, R. J. & Scott, M. P. Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog. Neuron 22, 103\u2013114. https:\/\/doi.org\/10.1016\/s0896-6273(00)80682-0 (1999).","journal-title":"Neuron"},{"key":"11857_CR9","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/s0960-9822(99)80195-x","volume":"9","author":"VA Wallace","year":"1999","unstructured":"Wallace, V. A. Purkinje-cell-derived Sonic Hedgehog regulates granule neuron precursor cell proliferation in the developing mouse cerebellum. Curr. Biol. 9, 445\u2013448. https:\/\/doi.org\/10.1016\/s0960-9822(99)80195-x (1999).","journal-title":"Curr. Biol."},{"key":"11857_CR10","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1523\/jneurosci.18-04-01478.1998","volume":"18","author":"H Komuro","year":"1998","unstructured":"Komuro, H. & Rakic, P. Distinct modes of neuronal migration in different domains of developing cerebellar cortex. J. Neurosci. 18, 1478\u20131490. https:\/\/doi.org\/10.1523\/jneurosci.18-04-01478.1998 (1998).","journal-title":"J. Neurosci."},{"key":"11857_CR11","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1523\/jneurosci.21-02-00527.2001","volume":"21","author":"H Komuro","year":"2001","unstructured":"Komuro, H., Yacubova, E., Yacubova, E. & Rakic, P. Mode and tempo of tangential cell migration in the cerebellar external granular layer. J. Neurosci. 21, 527\u2013540. https:\/\/doi.org\/10.1523\/jneurosci.21-02-00527.2001 (2001).","journal-title":"J. Neurosci."},{"key":"11857_CR12","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1126\/science.277.5329.1109","volume":"277","author":"LV Goodrich","year":"1997","unstructured":"Goodrich, L. V., Milenkovi\u0107, L., Higgins, K. M. & Scott, M. P. Altered neural cell fates and Medulloblastoma in mouse patched mutants. Science 277, 1109\u20131113. https:\/\/doi.org\/10.1126\/science.277.5329.1109 (1997).","journal-title":"Science"},{"key":"11857_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ccr.2008.07.003","volume":"14","author":"ZJ Yang","year":"2008","unstructured":"Yang, Z. J. et al. Medulloblastoma can be initiated by deletion of patched in lineage-restricted progenitors or stem cells. Cancer Cell. 14, 135\u2013145. https:\/\/doi.org\/10.1016\/j.ccr.2008.07.003 (2008).","journal-title":"Cancer Cell."},{"key":"11857_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1247005","volume":"343","author":"O Shalem","year":"2014","unstructured":"Shalem, O. et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343, 84\u201387. https:\/\/doi.org\/10.1126\/science.1247005 (2014).","journal-title":"Science"},{"key":"11857_CR15","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1158\/0008-5472.Can-14-2999-t","volume":"75","author":"X Zhao","year":"2015","unstructured":"Zhao, X. et al. RAS\/MAPK activation drives resistance to Smo inhibition, metastasis, and tumor evolution in Shh Pathway-Dependent tumors. Cancer Res. 75, 3623\u20133635. https:\/\/doi.org\/10.1158\/0008-5472.Can-14-2999-t (2015).","journal-title":"Cancer Res."},{"key":"11857_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s40478-024-01831-x","volume":"12","author":"F Tsiami","year":"2024","unstructured":"Tsiami, F. et al. Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in Sonic Hedgehog Medulloblastoma. Acta Neuropathol. Commun. 12, 125. https:\/\/doi.org\/10.1186\/s40478-024-01831-x (2024).","journal-title":"Acta Neuropathol. Commun."},{"key":"11857_CR17","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/dvdy.20551","volume":"234","author":"V Matei","year":"2005","unstructured":"Matei, V. et al. Smaller inner ear sensory epithelia in neurog 1 null mice are related to earlier hair cell cycle exit. Dev. Dyn. 234, 633\u2013650. https:\/\/doi.org\/10.1002\/dvdy.20551 (2005).","journal-title":"Dev. Dyn."},{"key":"11857_CR18","doi-asserted-by":"publisher","first-page":"10171","DOI":"10.1158\/0008-5472.Can-06-0657","volume":"66","author":"J Mao","year":"2006","unstructured":"Mao, J. et al. A novel somatic mouse model to survey tumorigenic potential applied to the Hedgehog pathway. Cancer Res. 66, 10171\u201310178. https:\/\/doi.org\/10.1158\/0008-5472.Can-06-0657 (2006).","journal-title":"Cancer Res."},{"key":"11857_CR19","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1038\/ncomms5181","volume":"5","author":"M Alvarez-Saavedra","year":"2014","unstructured":"Alvarez-Saavedra, M., De Repentigny, Y., Lagali, P. S., Ram, R. & Yan, E. V. Snf2h-mediated chromatin organization and histone H1 dynamics govern cerebellar morphogenesis and neural maturation. Nat. Commun. 5, 4181. https:\/\/doi.org\/10.1038\/ncomms5181 (2014).","journal-title":"Nat. Commun."},{"key":"11857_CR20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nbt.3437","volume":"34","author":"JG Doench","year":"2016","unstructured":"Doench, J. G. et al. Optimized SgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat. Biotechnol. 34, 184\u2013191. https:\/\/doi.org\/10.1038\/nbt.3437 (2016).","journal-title":"Nat. Biotechnol."},{"key":"11857_CR21","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1186\/s12864-018-4989-y","volume":"19","author":"F Iorio","year":"2018","unstructured":"Iorio, F. et al. Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targeting. BMC Genom. 19, 604. https:\/\/doi.org\/10.1186\/s12864-018-4989-y (2018).","journal-title":"BMC Genom."},{"key":"11857_CR22","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1186\/s13059-014-0554-4","volume":"15","author":"W Li","year":"2014","unstructured":"Li, W. et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol. 15, 554. https:\/\/doi.org\/10.1186\/s13059-014-0554-4 (2014).","journal-title":"Genome Biol."},{"key":"11857_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13073-020-00809-3","volume":"13","author":"E Kim","year":"2021","unstructured":"Kim, E. & Hart, T. Improved analysis of CRISPR fitness screens and reduced off-target effects with the BAGEL2 gene essentiality classifier. Genome Med. 13, 2. https:\/\/doi.org\/10.1186\/s13073-020-00809-3 (2021).","journal-title":"Genome Med."},{"key":"11857_CR24","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.cell.2015.11.015","volume":"163","author":"T Hart","year":"2015","unstructured":"Hart, T. et al. High-Resolution CRISPR screens reveal fitness genes and Genotype-Specific Cancer liabilities. Cell 163, 1515\u20131526. https:\/\/doi.org\/10.1016\/j.cell.2015.11.015 (2015).","journal-title":"Cell"},{"key":"11857_CR25","doi-asserted-by":"publisher","first-page":"13486","DOI":"10.1523\/jneurosci.2560-14.2014","volume":"34","author":"N Moreno","year":"2014","unstructured":"Moreno, N. et al. Loss of Smarc proteins impairs cerebellar development. J. Neurosci. 34, 13486\u201313491. https:\/\/doi.org\/10.1523\/jneurosci.2560-14.2014 (2014).","journal-title":"J. Neurosci."},{"key":"11857_CR26","doi-asserted-by":"publisher","first-page":"13611","DOI":"10.1038\/s41598-019-50088-1","volume":"9","author":"MH Robinson","year":"2019","unstructured":"Robinson, M. H. et al. Upregulation of the chromatin remodeler HELLS is mediated by YAP1 in Sonic Hedgehog Medulloblastoma. Sci. Rep. 9, 13611. https:\/\/doi.org\/10.1038\/s41598-019-50088-1 (2019).","journal-title":"Sci. Rep."},{"key":"11857_CR27","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.4049\/jimmunol.1301966","volume":"191","author":"AM Griesinger","year":"2013","unstructured":"Griesinger, A. M. et al. Characterization of distinct immunophenotypes across pediatric brain tumor types. J. Immunol. 191, 4880\u20134888. https:\/\/doi.org\/10.4049\/jimmunol.1301966 (2013).","journal-title":"J. Immunol."},{"key":"11857_CR28","doi-asserted-by":"publisher","first-page":"14097","DOI":"10.1073\/pnas.2336105100","volume":"100","author":"T Stopka","year":"2003","unstructured":"Stopka, T. & Skoultchi, A. I. The ISWI ATPase Snf2h is required for early mouse development. Proc. Natl. Acad. Sci. U S A. 100, 14097\u201314102. https:\/\/doi.org\/10.1073\/pnas.2336105100 (2003).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"11857_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.neuron.2005.08.028","volume":"48","author":"R Machold","year":"2005","unstructured":"Machold, R. & Fishell, G. Math1 is expressed in temporally discrete pools of cerebellar rhombic-lip neural progenitors. Neuron 48, 17\u201324. https:\/\/doi.org\/10.1016\/j.neuron.2005.08.028 (2005).","journal-title":"Neuron"},{"key":"11857_CR30","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1046\/j.1471-4159.2001.00324.x","volume":"77","author":"MA Lazzaro","year":"2001","unstructured":"Lazzaro, M. A. & Picketts, D. J. Cloning and characterization of the murine imitation switch (ISWI) genes: differential expression patterns suggest distinct developmental roles for Snf2h and Snf2l. J. Neurochem. 77, 1145\u20131156. https:\/\/doi.org\/10.1046\/j.1471-4159.2001.00324.x (2001).","journal-title":"J. Neurochem"},{"key":"11857_CR31","doi-asserted-by":"publisher","first-page":"5746","DOI":"10.1038\/onc.2016.108","volume":"35","author":"X Shi","year":"2016","unstructured":"Shi, X., Wang, Q., Gu, J., Xuan, Z. & Wu, J. I. SMARCA4\/Brg1 coordinates genetic and epigenetic networks underlying Shh-type Medulloblastoma development. Oncogene 35, 5746\u20135758. https:\/\/doi.org\/10.1038\/onc.2016.108 (2016).","journal-title":"Oncogene"},{"key":"11857_CR32","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/ng.336","volume":"41","author":"PA Northcott","year":"2009","unstructured":"Northcott, P. A. et al. Multiple recurrent genetic events converge on control of histone lysine methylation in Medulloblastoma. Nat. Genet. 41, 465\u2013472. https:\/\/doi.org\/10.1038\/ng.336 (2009).","journal-title":"Nat. Genet."},{"key":"11857_CR33","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1126\/science.1198056","volume":"331","author":"DW Parsons","year":"2011","unstructured":"Parsons, D. W. et al. The genetic landscape of the childhood cancer Medulloblastoma. Science 331, 435\u2013439. https:\/\/doi.org\/10.1126\/science.1198056 (2011).","journal-title":"Science"},{"key":"11857_CR34","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature11329","volume":"488","author":"TJ Pugh","year":"2012","unstructured":"Pugh, T. J., Weeraratne, S. D., Archer, T. C., Krummel, P. & Auclair, D. A. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature 488, 106\u2013110. https:\/\/doi.org\/10.1038\/nature11329 (2012).","journal-title":"Nature"},{"key":"11857_CR35","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ccr.2014.02.004","volume":"25","author":"M Kool","year":"2014","unstructured":"Kool, M. et al. Genome sequencing of SHH Medulloblastoma predicts genotype-related response to smoothened Inhibition. Cancer Cell. 25, 393\u2013405. https:\/\/doi.org\/10.1016\/j.ccr.2014.02.004 (2014).","journal-title":"Cancer Cell."},{"key":"11857_CR36","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1038\/s41467-021-21883-0","volume":"12","author":"P Skowron","year":"2021","unstructured":"Skowron, P. et al. The transcriptional landscape of Shh Medulloblastoma. Nat. Commun. 12, 1749. https:\/\/doi.org\/10.1038\/s41467-021-21883-0 (2021).","journal-title":"Nat. Commun."},{"key":"11857_CR37","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.devcel.2018.02.012","volume":"44","author":"DJ Merk","year":"2018","unstructured":"Merk, D. J. et al. Opposing effects of CREBBP mutations govern the phenotype of Rubinstein-Taybi syndrome and adult SHH Medulloblastoma. Dev. Cell. 44, 709\u2013724e706. https:\/\/doi.org\/10.1016\/j.devcel.2018.02.012 (2018).","journal-title":"Dev. Cell."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11857-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11857-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11857-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T10:43:16Z","timestamp":1756896196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11857-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11857"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-11857-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"16 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ghazaleh Tabatabai has served on advisory boards (Bayer, Boehringer Ingelheim, CureVac, Miltenyi Biomedicine, Novocure), as a consultant (Bayer, Boehringer Ingelheim, CureVac), as steering committee member in non-interventional trials (Bayer, Novocure), as a speaker (Novocure, Servier), and financial compensation for all these activities was provided as institutional funding to the University Hospital T\u00fcbingen. All other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26091"}}